ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 4126434

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.

Rowley JD. Nature, 1973. Cited by 3,663 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Papers, record 4126434. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4126434

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.
PubMed
Journal
Nature
PubMed
Year
1973
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3,663
iCite
Relative citation ratio, by iCite
61
iCite
Revised in PubMed
2023-11-20
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rowley JDJ D

Source PubMed

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chromosome AberrationsMajor topic
Chromosome DisordersMajor topic
Chromosomes, Human, 21-22 and YMajor topic
Chromosomes, Human, 6-12 and XMajor topic
Leukemia, MyeloidMajor topic
Adolescent
Adult
Aged
Bone Marrow Cells
Fluorescent Dyes
Humans
Karyotyping
Leukocytes
Methods
Middle Aged
Mitosis
Quinacrine
Staining and Labeling

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00390897Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid LeukaemiaBackground

Source ClinicalTrials.gov

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by1,223

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3,663 citations.

PMIDTitleJournalYearIn PapersSource
42,939,570In Vitro Chromosome Translocations: Modeling Critical Drivers of Human Neoplasms.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42939570PubMed
42,886,318Next-generation digital polymerase chain reaction assay for BCR::ABL1 in chronic myeloid leukemia: comprehensive validation for standardized measurable residual disease detection.Blood Res2026https://conductscience.org/library/papers/42886318PubMed
42,857,662Comparative Outcomes of Generic and Branded Dasatinib in Chronic-Phase Chronic Myeloid Leukemia: A Single-Center Within-Patient Analysis.J Blood Med2026https://conductscience.org/library/papers/42857662PubMed
42,751,219Molecules of lung cancer - fusion alterations in nonsmall cell lung cancer: biology and diagnostic considerations.Breathe (Sheff)2026https://conductscience.org/library/papers/42751219PubMed
42,729,957Design, synthesis, molecular docking and anticancer activity of novel N-(4-(chlorodifluoromethoxy)phenyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives.RSC Adv2026https://conductscience.org/library/papers/42729957PubMed
42,707,694Mitochondrial DNA mutations are associated with impaired oxidative phosphorylation and enhanced imatinib response in chronic myeloid leukemia.Hemasphere2026https://conductscience.org/library/papers/42707694PubMed
42,671,651Cancer-associated fusion transcripts: mechanisms, functional roles, and clinical implications.Clin Exp Med2026https://conductscience.org/library/papers/42671651PubMed
42,645,798The CD70/CD27 Axis in Tyrosine Kinase Inhibitor-Treated Chronic Phase Chronic Myeloid Leukemia Cells Is Not an Achilles Heel.Hematol Rep2026https://conductscience.org/library/papers/42645798PubMed
42,583,136Secondary Diffuse Large B-Cell Lymphoma After Sequential Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: A Case Report.Case Rep Hematol2026https://conductscience.org/library/papers/42583136PubMed
42,549,430Clonal and genomic determinants of e1a2 BCR::ABL1 chronic myeloid leukemia: A Fi-LMC study.Hemasphere2026https://conductscience.org/library/papers/42549430PubMed

1 to 10 of 1,223

See all 1,223 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
LOC107963955107,963,955PubTator's text mininghttps://conductscience.org/library/genes/107963955NCBI Gene
LOC107980440107,980,440PubTator's text mininghttps://conductscience.org/library/genes/107980440NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4126434

GET https://conductscience.org/api/papers/v1/4126434/cited_by?page=2

API referenceFor AI assistants